课题基金 / 基金详情

PUS7介导成骨细胞S100A6假尿苷修饰调控破骨细胞分化维持骨骼稳态的机制研究

批准号:
82102518
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
周太峰
依托单位:
学科分类:
运动系统结构、功能和发育异常
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
周太峰

项目摘要

结项摘要

相似基金

相关文献

中文摘要
骨骼稳态失衡导致骨质疏松症,但其分子调控网络未完全阐明。假尿苷合酶7(PUS7)调控RNA转录后假尿苷修饰,其突变可致表现为身材矮小的综合征,然而,PUS7是否调控骨骼稳态未见报道。申报人前期发现,Pus7全敲小鼠骨量下降,体内破骨细胞活性增强,而成骨细胞活性未见差异;体外实验发现,Pus7敲除的骨髓巨噬细胞(BMM)破骨分化未见差异,而Pus7敲除的骨髓间充质细胞(BMSC)促进共培养野生BMM破骨分化。深入研究发现,Pus7敲除致S100a6翻译效率上调,且S100A6蛋白促进野生型BMM破骨分化。综上,申报人提出“PUS7介导成骨细胞S100A6假尿苷修饰调控破骨细胞分化维持骨骼稳态”的科研假设,拟应用转基因小鼠、细胞培养、核糖体印迹测序等方法,从体内和体外两方面揭示PUS7介导成骨细胞S100A6假尿苷修饰调控破骨细胞分化维持骨骼稳态的分子机制,有望为骨质疏松症提供新治疗靶点。
英文摘要
Disruption of bone homeostasis leads to osteoporosis, but the regulatory network of bone homeostasis has not been fully elucidated. Pseudouridine synthase 7 (PUS7) is responsible for pseudouridylation, which is an important post-transcriptional modification in RNA. Mutations in PUS7 have been recently reported to cause intellectual developmental disorder with abnormal behavior, microcephaly and short stature (IDDABS), however, the role of PUS7 in regulating bone homeostasis is still little known. We previously found that global knockout of Pus7 led to significantly reduced bone mass and enhanced osteoclast activity in vivo, without differences in osteoblast activity. Importantly, Pus7 null bone marrow stromal cells (BMSC) promoted the osteoclastogenesis of co-cultured bone marrow macrophages (BMM), but Pus7 null BMM showed no differences in osteoclastogenesis. Further findings showed that Pus7 knockout led to increased translational efficiency of S100a6, and S100A6 recombinant protein promoted the osteoclastogenesis of wild type BMM. In summary, we propose the hypothesis that PUS7 maintains bone homeostasis by regulating osteoblast-mediated osteoclastogenesis via S100A6 pseudouridylation. In this project, we plan to utilize transgenic mice, primary BMSC/BMM and ribosome sequencing, try to study the molecular mechanism underlying PUS7 maintained bone homeostasis by osteoblast-mediated osteoclastogenesis via S100A6 pseudouridylation, and aim to report a new therapy target for osteoporosis.
骨质疏松症正成为我国50岁以上人群的重要健康问题,骨骼稳态失衡是其主导病因。筛选骨骼稳态的新调控分子,为早期诊断、早期干预和再生修复提供依据和靶点,依然是当下骨质疏松症的研究热点与难点之一。项目负责人在前期研究的基础上,按照标书中既定工作计划,对PUS7调控骨骼稳态的作用及机制进行了深入探索。.首先,我们构建了Pus7敲除小鼠(KO)。研究发现8周龄KO小鼠出现明显的骨质疏松表型,KO和WT小鼠的骨形成速率无明显差异,而KO小鼠中单位骨面积破骨细胞的数量显著增多,提示KO小鼠的骨量下降是骨骼重塑失衡的结果,由破骨细胞增多所致。同时,为了进一步验证PUS7在成骨细胞和破骨细胞中的功能,我们构建了成骨细胞特异性敲除Pus7小鼠(CKOSp7)和破骨细胞特异性敲除Pus7小鼠(CKOLyz)。研究发现,8周龄CKOSp7小鼠出现明显的骨质疏松表型,而WTSp7和CKOSp7小鼠的骨形成速率无显著差异,CKOSp7小鼠中单位骨面积破骨细胞的数量显著增多。而8周龄CKOLyz小鼠的骨密度与WTLyz相比无显著差异,这两种转基因小鼠的骨骼表型进一步证明,Pus7KO小鼠骨骼表型主要与成骨细胞Pus7表达相关,成骨细胞假尿嘧啶化是影响成骨-破骨失衡导致骨质疏松的主导因素。.此外,我们发现RNA的假尿嘧啶化修饰随着成骨细胞的衰老逐渐减少。在成骨细胞衰老过程中,Pus7的表达逐渐减少。敲除成骨细胞Pus7导致其假尿嘧啶化修饰显著下降。这一结果证明了Pus7介导成骨细胞的RNA假尿嘧啶化修饰的主导作用。在分子机制方面,我们应用单细胞测序技术探索了KO小鼠的骨髓微环境改变,发现KO小鼠骨髓微环境的炎性改变,提示PUS7通过影响骨髓微环境炎性改变介导骨骼稳态。.因此,本研究应用转基因小鼠、细胞培养、单细胞转录组测序等方法,从体内和体外两方面揭示PUS7了介导假尿苷修饰调控破骨细胞分化维持骨骼稳态的分子机制,该研究将为骨质疏松症提供新治疗靶点。
国内基金
海外基金